CARISMA : Cardiac Arrhythmias and Risk Stratification After MyoCardial Infarction

Medtronic Cardiac Rhythm and Heart Failure312 enrolled

Overview

The purpose of this study is to assess the incidence of tachy- and bradyarrhythmic episodes in patients with acute myocardial infarction with depressed ventricular function and to determine the predictive value of several invasive and non-invasive risk markers for life-threatening arrhythmia

Study Type

OBSERVATIONAL

Enrollment

312

Conditions

Acute Myocardial Infarction

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Acute myocardial infarction (\< 21 days) * Ejection fraction \<= 40 % or wall motion index \<= 1.3 Exclusion Criteria: * Implantable loop recorder can't be implanted within 3 weeks after MI * NYHA class IV * Planned or previous ICD implantation * Planned CABG * Severe valvular disease * Pregnancy * Life expectancy \< 1 year for non-cardiac cause

Locations (1)

Medtronic Bakken Research Center B.V.

Maastricht, Netherlands

Outcomes

Primary Outcomes

ECG-documented Ventricular Fibrillation or Symptomatic Sustained Ventricular Tachycardia (VT)

ECG-documented ventricular fibrillation or symptomatic sustained ventricular tachycardia (VT)

Time frame: 2 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.